RESQ PHARMA Trademark

Trademark Overview


On Friday, November 8, 2024, a trademark application was filed for RESQ PHARMA with the United States Patent and Trademark Office. The USPTO has given the RESQ PHARMA trademark a serial number of 98844592. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 17, 2025. This trademark is owned by ResQ Pharma, Inc.. The RESQ PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe and set for administering the lipid emulsion, all for use in treating anesthetic and drug toxicity; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe and set for administering the lipid emulsion, all for use in resuscitating patients; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe and set for administering the lipid emulsion, all for use in treating cardiac arrest due to ischemia and cardiac failure; syringes that are used for administering lipid emulsions in the nature of syringes sold filled with a pharmaceutical, namely, a lipid emulsion for use in treating anesthetic and drug toxicity, treating neurological t...
resq pharma

General Information


Serial Number98844592
Word MarkRESQ PHARMA
Filing DateFriday, November 8, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, June 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 17, 2025

Trademark Statements


Goods and ServicesMedical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe and set for administering the lipid emulsion, all for use in treating anesthetic and drug toxicity; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe and set for administering the lipid emulsion, all for use in resuscitating patients; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe and set for administering the lipid emulsion, all for use in treating cardiac arrest due to ischemia and cardiac failure; syringes that are used for administering lipid emulsions in the nature of syringes sold filled with a pharmaceutical, namely, a lipid emulsion for use in treating anesthetic and drug toxicity, treating neurological toxicity, treating cardiac arrest due to ischemia, treating cardiac failure, treating cardiac toxicity, and for resuscitating patients
NOT AVAILABLE"PHARMA"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameResQ Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60612

Party NameResQ Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60612

Trademark Events


Event DateEvent Description
Friday, November 8, 2024NEW APPLICATION ENTERED
Sunday, May 4, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 7, 2025ASSIGNED TO EXAMINER
Tuesday, May 13, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 13, 2025EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 13, 2025EXAMINERS AMENDMENT E-MAILED
Tuesday, May 13, 2025EXAMINER'S AMENDMENT ENTERED
Wednesday, June 11, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 17, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 17, 2025PUBLISHED FOR OPPOSITION